ZA200704874B - Preventive or therapeutic agent for glaucoma - Google Patents
Preventive or therapeutic agent for glaucomaInfo
- Publication number
- ZA200704874B ZA200704874B ZA200704874A ZA200704874A ZA200704874B ZA 200704874 B ZA200704874 B ZA 200704874B ZA 200704874 A ZA200704874 A ZA 200704874A ZA 200704874 A ZA200704874 A ZA 200704874A ZA 200704874 B ZA200704874 B ZA 200704874B
- Authority
- ZA
- South Africa
- Prior art keywords
- glaucoma
- therapeutic agent
- preventive
- salt
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63811804P | 2004-12-23 | 2004-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200704874B true ZA200704874B (en) | 2008-08-27 |
Family
ID=36601805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200704874A ZA200704874B (en) | 2004-12-23 | 2005-12-22 | Preventive or therapeutic agent for glaucoma |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1818059B1 (ja) |
JP (1) | JP4099201B2 (ja) |
KR (1) | KR101286813B1 (ja) |
CN (1) | CN101087613B (ja) |
AT (1) | ATE415972T1 (ja) |
AU (1) | AU2005320085B2 (ja) |
BR (1) | BRPI0519007A2 (ja) |
CA (1) | CA2585372A1 (ja) |
CY (1) | CY1108651T1 (ja) |
DE (1) | DE602005011476D1 (ja) |
DK (1) | DK1818059T3 (ja) |
EA (1) | EA011085B1 (ja) |
ES (1) | ES2317338T3 (ja) |
HK (1) | HK1113312A1 (ja) |
MX (1) | MX2007007614A (ja) |
MY (1) | MY138811A (ja) |
NO (1) | NO20072187L (ja) |
NZ (1) | NZ555137A (ja) |
PL (1) | PL1818059T3 (ja) |
PT (1) | PT1818059E (ja) |
SI (1) | SI1818059T1 (ja) |
TW (1) | TWI367098B (ja) |
WO (1) | WO2006068208A1 (ja) |
ZA (1) | ZA200704874B (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090079689A1 (en) * | 2005-07-14 | 2009-03-26 | Akio Miyata | Display Device And Electric Apparatus Using The Same |
CN102099037A (zh) | 2008-07-25 | 2011-06-15 | 旭化成制药株式会社 | 含有磺酰胺化合物的稳定的水溶液组合物 |
TW201235040A (en) * | 2011-02-04 | 2012-09-01 | Kowa Co | Drug therapy for preventing or treating glaucoma |
EA026904B1 (ru) * | 2012-11-23 | 2017-05-31 | Игорь Михайлович Юхт | Способ количественного определения полигексаметиленбигуанидина (пгмб) гидрохлорида в составах для приготовления жидких лекарственных средств для лечения заболеваний глаз и носа (2 варианта) |
EP2990040B1 (en) * | 2013-04-24 | 2019-12-04 | Kyushu University, National University Corporation | Therapeutic agent for eyeground disease |
CA2962624C (en) * | 2014-09-25 | 2022-08-30 | Kowa Company, Ltd. | Pharmaceutical preparation comprising ripasudil and a polyolefin-based resin |
HUE048790T2 (hu) * | 2014-09-25 | 2020-09-28 | Kowa Co | Vizes készítmény |
JP5951920B1 (ja) | 2014-12-12 | 2016-07-13 | 興和株式会社 | 新規水性組成物 |
TWI699205B (zh) * | 2014-12-12 | 2020-07-21 | 日商興和股份有限公司 | 用於預防或治療青光眼之藥物療法 |
KR20160108121A (ko) | 2015-03-06 | 2016-09-19 | 코와 가부시키가이샤 | 수성 조성물 |
JP2018118905A (ja) * | 2015-04-27 | 2018-08-02 | 恵 本庄 | 白内障術後合併症の予防治療剤 |
CN106310285A (zh) * | 2015-06-15 | 2017-01-11 | 江苏吉贝尔药业股份有限公司 | 一种新的盐酸利舒地尔滴眼液及其制备方法 |
JP6886322B2 (ja) * | 2016-03-25 | 2021-06-16 | 興和株式会社 | 眼科用組成物 |
CN107164328A (zh) * | 2017-06-30 | 2017-09-15 | 太仓卡斯特姆新材料有限公司 | 一种高稳定性mcf‑7乳腺癌细胞的复苏方法 |
CN111479568A (zh) | 2017-12-21 | 2020-07-31 | 参天制药株式会社 | 司培前列素与Rho激酶抑制剂的组合药物 |
CA3207859A1 (en) | 2021-01-11 | 2022-07-14 | Incyte Corporation | Combination therapy comprising jak pathway inhibitor and rock inhibitor |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9401108D0 (sv) * | 1994-03-31 | 1994-03-31 | Leiras Oy | Ophthalmic composition I |
DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
JP3719609B2 (ja) * | 1995-12-21 | 2005-11-24 | アルコン ラボラトリーズ,インコーポレイテッド | 緑内障および眼虚血の治療のための特定のイソキノリンスルホニル化合物の使用 |
JPH10310576A (ja) * | 1997-03-10 | 1998-11-24 | Hiroyoshi Hidaka | イソキノリンスルフォンアミド誘導体及びこれを有効成分とする医薬 |
WO1999054306A1 (fr) * | 1997-03-10 | 1999-10-28 | Hiroyoshi Hidaka | Derives isoquinolinesulfonamide et medicaments integrant ces derives comme principe actif |
PL336586A1 (en) * | 1997-04-25 | 2000-07-03 | Pfizer | Pyrazoylpyrimidinones inhibiting the cyclic guanosine 3',5'-monophosphate phosphodiesterase of type 5 (cgmp pde5) for treating sexual disorders |
FR2777189B1 (fr) | 1998-04-09 | 2001-04-06 | Chauvin Lab Sa | Composition ophtalmique comprenant un beta-bloquant |
JP4212149B2 (ja) * | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 医薬 |
ES2372572T3 (es) | 1998-08-17 | 2012-01-23 | Senju Pharmaceutical Co., Ltd. | Agente para profilaxis y tratamiento de glaucoma. |
AP2001002103A0 (en) * | 1998-10-22 | 2001-03-31 | Neurosearch As | Substituted phenyl derivatives, their preparation and use. |
-
2005
- 2005-12-13 TW TW094144075A patent/TWI367098B/zh not_active IP Right Cessation
- 2005-12-14 MY MYPI20055888A patent/MY138811A/en unknown
- 2005-12-22 DE DE602005011476T patent/DE602005011476D1/de active Active
- 2005-12-22 EA EA200701134A patent/EA011085B1/ru not_active IP Right Cessation
- 2005-12-22 AT AT05819681T patent/ATE415972T1/de active
- 2005-12-22 WO PCT/JP2005/023570 patent/WO2006068208A1/ja active Application Filing
- 2005-12-22 MX MX2007007614A patent/MX2007007614A/es active IP Right Grant
- 2005-12-22 PT PT05819681T patent/PT1818059E/pt unknown
- 2005-12-22 ES ES05819681T patent/ES2317338T3/es active Active
- 2005-12-22 NZ NZ555137A patent/NZ555137A/en not_active IP Right Cessation
- 2005-12-22 DK DK05819681T patent/DK1818059T3/da active
- 2005-12-22 CA CA002585372A patent/CA2585372A1/en not_active Abandoned
- 2005-12-22 AU AU2005320085A patent/AU2005320085B2/en not_active Ceased
- 2005-12-22 ZA ZA200704874A patent/ZA200704874B/xx unknown
- 2005-12-22 SI SI200530540T patent/SI1818059T1/sl unknown
- 2005-12-22 KR KR1020077012207A patent/KR101286813B1/ko active Protection Beyond IP Right Term
- 2005-12-22 PL PL05819681T patent/PL1818059T3/pl unknown
- 2005-12-22 CN CN2005800444266A patent/CN101087613B/zh not_active Expired - Fee Related
- 2005-12-22 EP EP05819681A patent/EP1818059B1/en not_active Not-in-force
- 2005-12-22 BR BRPI0519007-0A patent/BRPI0519007A2/pt not_active IP Right Cessation
- 2005-12-22 JP JP2006549049A patent/JP4099201B2/ja active Active
-
2007
- 2007-04-27 NO NO20072187A patent/NO20072187L/no not_active Application Discontinuation
-
2008
- 2008-03-27 HK HK08103456.3A patent/HK1113312A1/xx not_active IP Right Cessation
- 2008-12-11 CY CY20081101444T patent/CY1108651T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ555137A (en) | 2009-10-30 |
MX2007007614A (es) | 2007-08-15 |
CY1108651T1 (el) | 2014-04-09 |
EP1818059A4 (en) | 2007-12-26 |
CN101087613B (zh) | 2010-08-18 |
ATE415972T1 (de) | 2008-12-15 |
CN101087613A (zh) | 2007-12-12 |
EP1818059A1 (en) | 2007-08-15 |
TW200628160A (en) | 2006-08-16 |
PT1818059E (pt) | 2008-12-31 |
SI1818059T1 (sl) | 2009-04-30 |
NO20072187L (no) | 2007-07-13 |
JP4099201B2 (ja) | 2008-06-11 |
AU2005320085B2 (en) | 2010-07-29 |
CA2585372A1 (en) | 2006-06-29 |
EA200701134A1 (ru) | 2007-10-26 |
TWI367098B (en) | 2012-07-01 |
WO2006068208A1 (ja) | 2006-06-29 |
MY138811A (en) | 2009-07-31 |
EP1818059B1 (en) | 2008-12-03 |
JPWO2006068208A1 (ja) | 2008-06-12 |
ES2317338T3 (es) | 2009-04-16 |
PL1818059T3 (pl) | 2009-05-29 |
HK1113312A1 (en) | 2008-10-03 |
AU2005320085A1 (en) | 2006-06-29 |
BRPI0519007A2 (pt) | 2008-12-23 |
KR101286813B1 (ko) | 2013-07-17 |
DK1818059T3 (da) | 2009-03-16 |
DE602005011476D1 (de) | 2009-01-15 |
EA011085B1 (ru) | 2008-12-30 |
KR20070090897A (ko) | 2007-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200704874B (en) | Preventive or therapeutic agent for glaucoma | |
WO2007076360A8 (en) | (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions | |
PL378030A1 (pl) | Czynniki które regulują, hamują lub modulują działanie i/lub wyrażanie czynnika wzrostowego tkanki łącznej (CTGF), jako wyjątkowe środki do obniżania ciśnienia śródgałkowego i leczenia retinopatii jaskrowej/neuropatii nerwu wzrokowego | |
WO2006066103A3 (en) | Ophthalmic implant for treatment of glaucoma | |
TW200633709A (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions | |
WO2002080811A3 (en) | Glaucoma stent and methods thereof for glaucoma treatment | |
AU2003274734A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
WO2007076367A3 (en) | Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma | |
WO2002098350A3 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
WO2003005941A3 (de) | Insert zur behandlung des trockenen auges | |
WO2007126364A8 (en) | Use of antisecretory factors for treating intraocular hypertension | |
WO2004069181A3 (en) | Composition for the treatment of intraocular pressure | |
HK1102913A1 (en) | Statins for the treatment of ocular hypertension and glaucoma | |
EP1752158A4 (en) | CORNEAL NEURITOGENESIS PROMOTER CONTAINING PACAP AND ITS DERIVATIVE | |
WO2005027884A3 (en) | Stabilized ocular solutions | |
WO2004019874A3 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
WO2007127711A3 (en) | Abnormal cannabidiols as agents for lowering intraocular pressure | |
EP1482922A4 (en) | AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS | |
WO2006061525A3 (fr) | Compositions pour le traitement des pathologies oculaires de surface | |
WO2004052283A3 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
EP1420791A4 (en) | USE OF COMPOUNDS FOR THE TREATMENT OF CONDITIONS CONSECUTIVE TO CORNEAL NERVE INJURY AFTER LASIK OR OTHER TRAUMA OR SURGERY OF THE EYE | |
TW200806284A (en) | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma | |
WO2009111169A3 (en) | Compositions comprising pkc-delta modulators and methods for ocular neuroprotection | |
WO2003101379A3 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
IL163938A0 (en) | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |